Literature DB >> 23749786

Reply to "[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.

Karl-Josef Langen, Norbert Galldiks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23749786      PMCID： PMC3688021          DOI： 10.1093/neuonc/not059

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  12 in total

Review 1.  O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.

Authors:  Karl-Josef Langen; Kurt Hamacher; Matthias Weckesser; Frank Floeth; Gabriele Stoffels; Dagmar Bauer; Heinz H Coenen; Dirk Pauleit
Journal:  Nucl Med Biol       Date:  2006-04       Impact factor: 2.408

2.  O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.

Authors:  Dirk Pauleit; Frank Floeth; Kurt Hamacher; Markus J Riemenschneider; Guido Reifenberger; Hans-Wilhelm Müller; Karl Zilles; Heinz H Coenen; Karl-Josef Langen
Journal:  Brain       Date:  2005-02-02       Impact factor: 13.501

3.  EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues.

Authors:  T Vander Borght; S Asenbaum; P Bartenstein; C Halldin; O Kapucu; K Van Laere; A Varrone; K Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11       Impact factor: 9.236

4.  18F-FET PET differentiation of ring-enhancing brain lesions.

Authors:  Frank W Floeth; Dirk Pauleit; Michael Sabel; Guido Reifenberger; Gabriele Stoffels; Walter Stummer; Frank Rommel; Kurt Hamacher; Karl-Josef Langen
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

5.  Comparison of O-(2-18F-fluoroethyl)-L-tyrosine and L-3H-methionine uptake in cerebral hematomas.

Authors:  Dagmar Salber; Gabriele Stoffels; Anna-Maria Oros-Peusquens; Nadim J Shah; Guido Reifenberger; Kurt Hamacher; Heinz H Coenen; Karl-Josef Langen
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

6.  Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence.

Authors:  Nicolas Spaeth; Matthias T Wyss; Bruno Weber; Stephan Scheidegger; Amelie Lutz; Jorn Verwey; Ivan Radovanovic; Jens Pahnke; Damian Wild; Gerrit Westera; Dominik Weishaupt; Dirk M Hermann; Barbara Kaser-Hotz; Adriano Aguzzi; Alfred Buck
Journal:  J Nucl Med       Date:  2004-11       Impact factor: 10.057

7.  Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia.

Authors:  Dagmar Salber; Gabriele Stoffels; Dirk Pauleit; Guido Reifenberger; Michael Sabel; Nadim Jon Shah; Kurt Hamacher; Heinz H Coenen; Karl-Josef Langen
Journal:  Nucl Med Biol       Date:  2006-11       Impact factor: 2.408

8.  Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.

Authors:  Gabriele Pöpperl; Claudia Götz; Walter Rachinger; Franz-Josef Gildehaus; Jörg-Christian Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-10       Impact factor: 9.236

9.  [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

Authors:  Markus Hutterer; Martha Nowosielski; Daniel Putzer; Nathalie L Jansen; Marcel Seiz; Michael Schocke; Mark McCoy; Georg Göbel; Christian la Fougère; Irene J Virgolini; Eugen Trinka; Andreas H Jacobs; Günther Stockhammer
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

10.  Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.

Authors:  Dagmar Salber; Gabriele Stoffels; Dirk Pauleit; Anna-Maria Oros-Peusquens; Nadim Jon Shah; Peter Klauth; Kurt Hamacher; Heinz Hubert Coenen; Karl-Josef Langen
Journal:  J Nucl Med       Date:  2007-11-15       Impact factor: 10.057
View more
  5 in total

1.  The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord.

Authors:  Caroline Tscherpel; Veronika Dunkl; Garry Ceccon; Gabriele Stoffels; Natalie Judov; Marion Rapp; Philipp T Meyer; Elena Rota Kops; Johannes Ermert; Gereon R Fink; Nadim J Shah; Karl-Josef Langen; Norbert Galldiks
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

2.  Influence of blood-brain barrier permeability on O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas.

Authors:  Carina Stegmayr; Ulrike Bandelow; Dennis Oliveira; Philipp Lohmann; Antje Willuweit; Christian Filss; Norbert Galldiks; Joachim H R Lübke; N Jon Shah; Johannes Ermert; Karl-Josef Langen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-09-09       Impact factor: 9.236

3.  Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.

Authors:  Carina Stegmayr; Michael Schöneck; Dennis Oliveira; Antje Willuweit; Christian Filss; Norbert Galldiks; N Jon Shah; Heinz H Coenen; Karl-Josef Langen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-08       Impact factor: 9.236

4.  O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis.

Authors:  Alexander Heinzel; Dirk Müller; Sareh Said Yekta-Michael; Garry Ceccon; Karl-Josef Langen; Felix M Mottaghy; Martin Wiesmann; Martin Kocher; Elke Hattingen; Norbert Galldiks
Journal:  Neuro Oncol       Date:  2017-09-01       Impact factor: 12.300

5.  Diagnostic and Prognostic Potential of 18F-FET PET in the Differential Diagnosis of Glioma Recurrence and Treatment-Induced Changes After Chemoradiation Therapy.

Authors:  Monica Celli; Paola Caroli; Elena Amadori; Donatella Arpa; Lorena Gurrieri; Giulia Ghigi; Patrizia Cenni; Giovanni Paganelli; Federica Matteucci
Journal:  Front Oncol       Date:  2021-10-04       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.